According to reports from NFL Network and ESPN, the discovery of the clots has necessitated a treatment plan that will keep the quarterback sidelined for a minimum of three months. While the situation is serious, both the organization and Hurts' agent, Nicole Lynn, have provided a positive outlook regarding his long-term health and future availability.
Medical diagnosis and recovery outlook
The medical issue was identified after an initial diagnosis of a superficial clot in the quarterback's calf. Subsequent examinations revealed a more complex condition, specifically a deep vein thrombosis and bilateral pulmonary emboli. Despite the severity of the diagnosis, the joint statement issued by the Eagles and Nicole Lynn emphasized that Hurts remains clinically stable and is not experiencing significant functional limitations.
The treatment protocol requires Hurts to remain on anticoagulation medication, which precludes him from participating in any contact football activities for the duration of his recovery. The statement confirmed that while he is unable to play, he will continue to maintain his conditioning and remain involved with the team in a non-contact capacity. Medical professionals involved in his care anticipate a full recovery, noting that they expect him to return to the field once he has completed his course of blood thinners.
The Eagles organization expressed optimism regarding the quarterback's prognosis, stating that they do not anticipate any long-term effects from the condition. As the team moves forward without their starting signal-caller, the focus remains on his health and the successful completion of his treatment plan. The club has not yet detailed specific plans for the quarterback position in his absence, but the immediate priority for the franchise is ensuring a smooth recovery process for Hurts.
